SCHEDULE 13D

Company

IGC Pharma, Inc.

Filed

May 21, 2024

Accession Number

0001185185-24-000580

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →